𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy

✍ Scribed by M. N. Vo; M. Evans; K. Leitzel; S. M. Ali; M. Wilson; L. Demers; D. B. Evans; A. Lipton


Book ID
106378028
Publisher
Springer US
Year
2008
Tongue
English
Weight
193 KB
Volume
119
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Elevated plasma tissue inhibitor of meta
✍ Allan Lipton; Suhail M. Ali; Kim Leitzel; Laurence Demers; Dean B. Evans; Peter πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

## Abstract ## BACKGROUND. Tissue inhibitors of metalloproteinase (TIMPs) have at least 2 different functions. They inhibit the catalytic activity of matrix metalloproteinases, and they act as growth factors. ## METHODS. Pretreatment ethylenediamine tetracetic acid plasma TIMP‐1 was assayed from

A randomized controlled trial of the eff
✍ A.J. Cunningham; C.V.I. Edmonds; G.P. Jenkins; H. Pollack; G.A. Lockwood; D. War πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

In order to test the effect of a psychological intervention on survival from cancer, 66 women with metastatic breast cancer, all receiving standard medical care, were randomly assigned into two groups; one group (n = 30) attended the psychological intervention, consisting of 35 weekly, 2 h sessions